The Development and Characterization of a Next-Generation Oncolytic Virus Armed with an Anti-PD-1 sdAb for Osteosarcoma Treatment <i>In Vitro</i>.

Cells · 2024 · PMC10886739 · PMID 38391964

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

barely significantno p-value reported

There was a barely significant increase in luminance over time for the NCFs with MOI of 10 ( t -test p -value 0.045).

also in 155 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.